Viewing Study NCT04400058


Ignite Creation Date: 2025-12-25 @ 12:22 AM
Ignite Modification Date: 2025-12-30 @ 8:56 PM
Study NCT ID: NCT04400058
Status: COMPLETED
Last Update Posted: 2024-01-18
First Post: 2020-05-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression
Sponsor: Octapharma
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-06-01
Start Date Type: ACTUAL
Primary Completion Date: 2022-02-01
Primary Completion Date Type: ACTUAL
Completion Date: 2022-02-01
Completion Date Type: ACTUAL
First Submit Date: 2020-05-21
First Submit QC Date: None
Study First Post Date: 2020-05-22
Study First Post Date Type: ACTUAL
Results First Submit Date: 2023-12-11
Results First Submit QC Date: None
Results First Post Date: 2024-01-18
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-01-16
Last Update Post Date: 2024-01-18
Last Update Post Date Type: ACTUAL